# Zenas BioPharma, Inc. (ZBIO): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Zenas BioPharma, Inc. (ZBIO) is 15/100, ranked against 24,000+ stocks in 35 markets (Quality 11, Value 21, Momentum 60, each scored against its sector).

- StockRank: 15/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 11, Value 21, Momentum 60: each a 0-100 percentile within Healthcare.
- Position: #22,532 overall, #2,093 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 27.24 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 1.0M.

Source: https://moatmap.ai/stock/ZBIO
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker